Chris Woods
Executive Director, Hubert-Yeargan Center for Global Health
Professor, Medicine and Global Health
Chief, Infectious Diseases Division, Durham VA Medical Center
Appointment:
Topics:
Countries:
Chris Woods
Executive Director, Hubert-Yeargan Center for Global Health
Professor, Medicine and Global Health
Chief, Infectious Diseases Division, Durham VA Medical Center
Dr. Woods is the Executive Director of the Hubert-Yeargan Center for Global Health. He is a professor in the Departments of Medicine and Pathology at Duke University; an adjunct professor in Epidemiology at the University of North Carolina at Chapel Hill School of Public Health; an adjunct professor in the Emerging Infections Program at the Duke-National University of Singapore Graduate Medical School. Clinically, he serves as Chief of Infectious Diseases and clinical microbiology, and hospital epidemiologist for the Durham VA Medical Center. Dr. Woods is board-certified in internal medicine, infectious diseases, and medical microbiology.
Dr. Woods attended Yale University and pursued his medical education and training at Duke University and public health training at UNC-Chapel Hill. He is a graduate of the Epidemic Intelligence Service (EIS) of the Centers for Disease Control and Prevention (CDC), where he served in the Meningitis and Special Pathogens Branch of the National Center for Infectious Diseases. He formulated his interest in global health at Tenwek Hospital in Bomet, Kenya during his internal medicine residency and while at CDC, Dr. Woods performed programmatic work and outbreak investigations throughout the U.S. and the developing world. He currently serves as the Director of Graduate Studies and the MSc for Global Health in the Duke Global Health Institute.
Dr. Woods has published over 130 peer-reviewed articles and has a particular interest in development of medical microbiology capacity in the developing world and the epidemiology of emerging and re-emerging infectious diseases. His research focuses on the development of novel diagnostic approaches to infectious disease and the potential for interspecies transmission of pathogens. His genomic approach to harnessing the host response for diagnosis of infectious diseases has been called a paradigm shift in the field. Dr. Woods is a partner in the Southeastern Center for Emerging Biological Threats, core PI of the Southeastern Research Center for Excellence on Emerging Infections and Biodefense, and a leader in the NIH-funded Vaccine and Therapeutics Evaluation Unit at Duke.
Courses
-
GLHLTH 771
One Health: From Philosophy to Practice
Projects
- An Innovative Model for Detecting Interspecies Disease Transmission and Novel Pathogen Detection at Lola Ya Bonobo Sanctuary, Democratic Republic of Congo
- An Innovative Model for Detecting Interspecies Disease Transmission and Novel Pathogen Detection at Lola Ya Bonobo Sanctuary, Democratic Republic of Congo
- Ebola Clinical Research Consortium
- Planning Grant for Emerging Virus Research Training in Sierra Leone
-
Global Febrile Illness Diagnostics
Sri Lanka, Tanzania, United States
-
Sri Lanka Emerging Acute Respiratory infection and febrile illness Characterization Study (SEARCh)
Sri Lanka
-
Austere Environment Consortium for Enhanced Sepsis Outcomes (ACESO)
United States, Cambodia, Egypt
-
Emerging Virus Research Training in Sierra Leone
United States
Publications
-
She X, Zhai Y, Henao R, Woods C, Chiu C, Ginsburg GS, et al. Adaptive multi-channel event segmentation and feature extraction for monitoring health outcomes. Ieee Trans Biomed Eng. 2020 Nov 17;PP.
-
Vanderburg S, Wijayaratne G, Danthanarayana N, Jayamaha J, Piyasiri B, Halloluwa C, et al. Outbreak of severe acute respiratory infection in Southern Province, Sri Lanka in 2018: a cross-sectional study. Bmj Open. 2020 Nov 6;10(11):e040612.
-
Shoff CJ, Townsend ML, Tillekeratne LG, Schulteis RD, Yarrington ME, Turner NA, et al. Improved empiric antibiotic prescribing for acute cystitis with use of local urinary antibiogram and clinical decision support system. Infect Control Hosp Epidemiol. 2020 Nov;41(11):1351–3.
-
Hostler CJ, Bertumen JB, Park LP, Wilkins SB, Woods CW. Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center. Am J Infect Control. 2020 Oct;48(10):1148–51.
-
See more publications at Scholars@Duke